On 26 February 2019, orphan designation (EU/3/19/2139) was granted by the European Commission to Clinical Network Services (UK) Limited, United Kingdom, for autologous adult live cultured osteoblasts for the treatment of non-traumatic osteonecrosis.
The sponsorship was transferred to Clinical Network Services (NL) B.V., the Netherlands, in March 2019.
Autologous adult live cultured osteoblasts
|Disease / condition||
Treatment of non-traumatic osteonecrosis
|Date of first decision||
|EU designation number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.